RecruitingNot ApplicableNCT06321133

High Flow Nasal Cannula Weaning in Acute Bronchiolitis

High Flow Nasal Cannula Weaning in Acute Bronchiolitis - an Open-label Randomized Controlled Trials


Sponsor

Kuopio University Hospital

Enrollment

50 participants

Start Date

Feb 13, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this clinical study is to compared two different strategies to end high flow nasal cannula treatment in acute bronchiolitis. This study compared the immediate ending of high flow treatment to weaning strategy, in which the flow rate is gradually decreased. The aim is to assess if the immediate ending shortens the hospitalization time and whether it is a safe strategy.


Eligibility

Min Age: 0 MonthsMax Age: 12 Months

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying High flow nasal cannula immediate ending and High flow nasal cannula weaning for people with acute bronchiolitis. The study is currently recruiting participants at 4 locations. People eligible for this study include aged 0 Months to 12 Months.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERHigh flow nasal cannula immediate ending

High flow is immediately ended

OTHERHigh flow nasal cannula weaning

High flow is gradually weaned by reducing the flow rate


Locations(4)

Siun Sote

Joensuu, Finland

Central Finland Hospital District

Jyväskylä, Finland

Kuopio University Hospital

Kuopio, Finland

Mikkeli Central Hospital

Mikkeli, Finland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06321133


Related Trials